Business models for value-based health care must navigate today’s fraud and abuse laws carefully and find innovative ways to ensure any incentives and compensation are compliant. Hear about what violates current fraud and abuse laws, potential penalties for violation, and possible developments in the regulatory framework that will impact value-based care models.
Rebecca L. Orttel, Senior Legal Director, Americas, Medtronic
Philip J. Paseltiner, VP, Legal – Operational Solutions and Services, Siemens Healthineers
Nathana Sharma, Senior Product and Commercial Counsel, Labelbox; Policy and Corporate Counsel, MobileCoin
Moderated by: Betsy Mountenay, Analysis Manager, Bloomberg Law
